#JNOLive | February 16, 2021
Milind Y. Desai, MD, MBA, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a randomized clinical trial examining whether high-dose zinc and/or high-dose ascorbic acid reduces the severity or duration of symptoms compared with usual care among ambulatory patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Read the article here:
#JNOLive is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Subscribe to this channel for details on the next broadcast.
———————————————————————————
For more from JAMA
•
•
•
•
Follow the JAMA Network
•
•
•
•
•
•
